Breaking News Instant updates and real-time market news.

BPMC

Blueprint Medicines

$79.49 /

+1.29 (+1.65%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

19:59
09/20/20
09/20
19:59
09/20/20
19:59

Blueprint Medicines reports ARROW trial data at ESMO

Blueprint Medicines (BPMC) has announced results from the ongoing ARROW clinical trial showing durable responses and a well-tolerated safety profile for GAVRETO in patients with advanced RET-mutant medullary thyroid cancer. In these registrational data, GAVRETO demonstrated consistent clinical activity in patients across lines of therapy and regardless of RET mutation genotypes, including a high response rate in patients with gatekeeper mutations resistant to multi-kinase inhibitors. The results were presented in a proffered paper session during the European Society for Medical Oncology Virtual Congress 2020. As previously announced, the U.S. Food and Drug Administration has accepted a new drug application for GAVRETO for the treatment of patients with advanced or metastatic RET-mutant MTC and RET fusion-positive thyroid cancer. This NDA was accepted for priority review under the FDA's Real-Time Oncology Review pilot program, which aims to explore a more efficient review process to ensure safe and effective treatments are available to patients as early as possible. In addition, Blueprint Medicines has announced that the National Comprehensive Cancer Network has updated its Clinical Practice Guidelines in Oncology for Non-Small Cell Lung Cancer to include GAVRETO as a preferred treatment option for patients with RET fusion-positive NSCLC as a first-line or subsequent therapy. This rating indicates that there is uniform NCCN consensus that the intervention is appropriate. The NCCN Guidelines are the recognized clinical standard for cancer care by U.S. healthcare providers and payers, and are maintained by a committee of expert physicians from leading U.S. cancer centers. GAVRETO is being jointly commercialized by Genentech, a wholly owned member of the Roche Group (RHHBY), and Blueprint Medicines in the U.S. and will be commercialized by Roche outside of the U.S., excluding Greater China.

BPMC

Blueprint Medicines

$79.49 /

+1.29 (+1.65%)

RHHBY

Roche

$0.00 /

+ (+0.00%)

  • 21

    Sep

  • 23

    Sep

  • 23

    Nov

  • 23

    Nov

  • 23

    Jan

BPMC Blueprint Medicines
$79.49 /

+1.29 (+1.65%)

09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
07/15/20 Deutsche Bank
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
RHHBY Roche
$0.00 /

+ (+0.00%)

09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
08/18/20 Morgan Stanley
Roche price target raised to CHF 372 from CHF 370 at Morgan Stanley
07/29/20 UBS
Roche price target raised to CHF 390 from CHF 380 at UBS
07/29/20 Morgan Stanley
Roche price target raised to CHF 375 from CHF 370 at Morgan Stanley

TODAY'S FREE FLY STORIES

Options
Rite Aid call volume above normal and directionally bullish » 12:25
11/25/20
11/25
12:25
11/25/20
12:25
RAD

Rite Aid

$12.38 /

+1.22 (+10.93%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
09/25/20 Deutsche Bank
Rite Aid price target lowered to $9 from $18 at Deutsche Bank
09/24/20 Evercore ISI
Rite Aid price target lowered to $4 from $6 at Evercore ISI
RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

RAD Rite Aid
$12.38 /

+1.22 (+10.93%)

Recommendations
Ero Copper price target lowered to C$24 from C$26 at BMO Capital » 12:23
11/25/20
11/25
12:23
11/25/20
12:23
ERRPF

Ero Copper

$0.00 /

+ (+0.00%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERRPF Ero Copper
$0.00 /

+ (+0.00%)

ERRPF Ero Copper
$0.00 /

+ (+0.00%)

09:39 Today Scotiabank
Ero Copper price target raised to C$22.50 from C$22 at Scotiabank
08:59 Today Raymond James
Ero Copper price target raised to C$23 from C$21.50 at Raymond James
11/12/20 Scotiabank
Ero Copper price target raised to C$22 from C$21 at Scotiabank
10/22/20 National Bank
Ero Copper price target raised to C$20.50 from C$19.50 at National Bank
Recommendations
Planet 13 Holdings price target raised to C$6.50 from C$6 at Canaccord » 12:18
11/25/20
11/25
12:18
11/25/20
12:18
PLNHF

Planet 13 Holdings

$0.00 /

+ (+0.00%)

Canaccord analyst Bobby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

07:48 Today Northland
Planet 13 Holdings price target raised to $5.50 from $4 at Northland
11/23/20 Canaccord
Planet 13 Holdings price target raised to C$6 from C$5.50 at Canaccord
09/15/20 Canaccord
Planet 13 Holdings target raised to C$5.50 at Canaccord on Nevada recovery
07/21/20 Canaccord
Planet 13 Holdings price target raised to C$3.50 from C$2.50 at Canaccord
PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

PLNHF Planet 13 Holdings
$0.00 /

+ (+0.00%)

Technical Analysis
NASDAQ market internals summary » 12:17
11/25/20
11/25
12:17
11/25/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Galmed price target lowered to $20 from $25 at Canaccord » 12:17
11/25/20
11/25
12:17
11/25/20
12:17
GLMD

Galmed

$3.76 /

-0.02 (-0.53%)

Canaccord analyst Edward…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLMD Galmed
$3.76 /

-0.02 (-0.53%)

GLMD Galmed
$3.76 /

-0.02 (-0.53%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GLMD Galmed
$3.76 /

-0.02 (-0.53%)

Technical Analysis
NYSE market internals summary » 12:16
11/25/20
11/25
12:16
11/25/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Recommendations
Genmab price target lowered to DKK 2,630 from DKK 2,680 at UBS » 12:11
11/25/20
11/25
12:11
11/25/20
12:11
GNMSF

Genmab

$0.00 /

+ (+0.00%)

UBS analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNMSF Genmab
$0.00 /

+ (+0.00%)

08/13/20 Barclays
Genmab price target raised to DKK 2,475 from DKK 2,400 at Barclays
07/10/20 Barclays
Genmab price target raised to DKK 2,400 from DKK 2,250 at Barclays
Recommendations
UCB price target lowered to EUR 97 from EUR 112 at UBS » 12:09
11/25/20
11/25
12:09
11/25/20
12:09
UCBJY

UCB

$0.00 /

+ (+0.00%)

UBS analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UCBJY UCB
$0.00 /

+ (+0.00%)

UCBJY UCB
$0.00 /

+ (+0.00%)

07/31/20 UBS
UCB downgraded to Neutral from Buy at UBS
07/28/20 JPMorgan
UCB price target raised to EUR 124 from EUR 114 at JPMorgan
06/15/20 Oddo BHF
UCB upgraded to Buy from Neutral at Oddo BHF
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
Options
Slack call volume above normal and directionally bullish » 12:05
11/25/20
11/25
12:05
11/25/20
12:05
WORK

Slack Technologies

$35.90 /

+6.33 (+21.41%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
11/23/20 KeyBanc
Slack Technologies initiated with a Sector Weight at KeyBanc
10/23/20 Barclays
Slack Technologies price target raised to $36 from $31 at Barclays
10/21/20
Fly Intel: Top five analyst downgrades
WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

WORK Slack Technologies
$35.90 /

+6.33 (+21.41%)

Hot Stocks
Rayonier Advanced Materials falls -10.1% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
RYAM

Rayonier Advanced Materials

$6.31 /

-0.73 (-10.37%)

Rayonier Advanced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RYAM Rayonier Advanced Materials
$6.31 /

-0.73 (-10.37%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.73 (-10.37%)

10/20/20
Fly Intel: Top five analyst upgrades
10/20/20 RBC Capital
Rayonier Advanced Materials upgraded to Outperform at RBC Capital
10/20/20 RBC Capital
Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital
06/19/20
Fly Intel: Top five analyst upgrades
RYAM Rayonier Advanced Materials
$6.31 /

-0.73 (-10.37%)

RYAM Rayonier Advanced Materials
$6.31 /

-0.73 (-10.37%)

Hot Stocks
Genworth falls -13.2% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
GNW

Genworth

$3.97 /

-0.585 (-12.86%)

Genworth is down -13.2%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNW Genworth
$3.97 /

-0.585 (-12.86%)

GNW Genworth
$3.97 /

-0.585 (-12.86%)

GNW Genworth
$3.97 /

-0.585 (-12.86%)

GNW Genworth
$3.97 /

-0.585 (-12.86%)

Hot Stocks
Gap falls -19.4% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
GPS

Gap

$21.64 /

-5.25 (-19.52%)

Gap is down -19.4%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPS Gap
$21.64 /

-5.25 (-19.52%)

GPS Gap
$21.64 /

-5.25 (-19.52%)

10:04 Today
Fly Intel: Top five analyst downgrades
07:59 Today Baird
Gap price target raised to $25 from $23 at Baird
07:49 Today B. Riley Securities
Gap price target raised to $31 from $22 at B. Riley Securities
06:30 Today Citi
Gap downgraded to Neutral from Buy at Citi
GPS Gap
$21.64 /

-5.25 (-19.52%)

GPS Gap
$21.64 /

-5.25 (-19.52%)

GPS Gap
$21.64 /

-5.25 (-19.52%)

GPS Gap
$21.64 /

-5.25 (-19.52%)

General news
EIA natural gas storage change for week ending November 20 » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
USO

United States Oil Fund

$31.24 /

+0.43 (+1.40%)

Gas inventories 18 Bcf…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USO United States Oil Fund
$31.24 /

+0.43 (+1.40%)

USO United States Oil Fund
$31.24 /

+0.43 (+1.40%)

USO United States Oil Fund
$31.24 /

+0.43 (+1.40%)

Hot Stocks
Eastman Kodak rises 16.9% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
KODK

Eastman Kodak

$8.15 /

+1.18 (+16.93%)

Eastman Kodak is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KODK Eastman Kodak
$8.15 /

+1.18 (+16.93%)

KODK Eastman Kodak
$8.15 /

+1.18 (+16.93%)

KODK Eastman Kodak
$8.15 /

+1.18 (+16.93%)

KODK Eastman Kodak
$8.15 /

+1.18 (+16.93%)

KODK Eastman Kodak
$8.15 /

+1.18 (+16.93%)

Hot Stocks
Nordstrom rises 17.5% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
JWN

Nordstrom

$28.82 /

+4.17 (+16.92%)

Nordstrom is up 17.5%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

08:08 Today Credit Suisse
Nordstrom price target raised to $26 from $17 at Credit Suisse
07:08 Today Barclays
Nordstrom price target raised to $19 from $12 at Barclays
06:19 Today Citi
Nordstrom price target raised to $26 from $17 at Citi
11/09/20 Telsey Advisory
Nordstrom upgraded to Outperform from Market Perform at Telsey Advisory
JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

JWN Nordstrom
$28.82 /

+4.17 (+16.92%)

Hot Stocks
Fisker rises 22.3% » 12:00
11/25/20
11/25
12:00
11/25/20
12:00
FSR

Fisker

$19.53 /

+3.585 (+22.48%)

Fisker is up 22.3%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSR Fisker
$19.53 /

+3.585 (+22.48%)

FSR Fisker
$19.53 /

+3.585 (+22.48%)

10:04 Today
Fly Intel: Top five analyst initiations
05:58 Today Citi
Fisker initiated with a Buy, $26 price target at Citi
11/17/20 Wedbush
EV demand could see surge of growth in 2021, says Wedbush
11/09/20
Fly Intel: Top five analyst initiations
FSR Fisker
$19.53 /

+3.585 (+22.48%)

FSR Fisker
$19.53 /

+3.585 (+22.48%)

Recommendations
Compass Group price target lowered to $1,400 from $1,420 at UBS » 11:59
11/25/20
11/25
11:59
11/25/20
11:59
CMPGY

Compass Group

$0.00 /

+ (+0.00%)

UBS analyst Jarrod Castle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPGY Compass Group
$0.00 /

+ (+0.00%)

11/18/20 UBS
Compass Group downgraded to Neutral from Buy at UBS
11/17/20 Goldman Sachs
Compass Group downgraded to Neutral from Buy at Goldman Sachs
11/12/20 Jefferies
Compass Group downgraded to Hold from Buy at Jefferies
10/13/20 Berenberg
Compass Group price target raised to 1,425 GBp from 1,350 GBp at Berenberg
Recommendations
Prosus price target raised to EUR 118 from EUR 112 at UBS » 11:57
11/25/20
11/25
11:57
11/25/20
11:57
PROSY

Prosus

$0.00 /

+ (+0.00%)

UBS analyst John Kim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PROSY Prosus
$0.00 /

+ (+0.00%)

11/24/20 Barclays
Prosus price target raised to EUR 128.50 from EUR 128 at Barclays
11/17/20 Barclays
Prosus price target raised to EUR 128 from EUR 112 at Barclays
11/16/20 JPMorgan
Prosus price target raised to EUR 120 from EUR 116 at JPMorgan
11/02/20 Deutsche Bank
Prosus price target raised to EUR 120 from EUR 105 at Deutsche Bank
Recommendations
Novartis price target raised to CHF 99 from CHF 98 at UBS » 11:57
11/25/20
11/25
11:57
11/25/20
11:57
NVS

Novartis

$89.25 /

+0.94 (+1.06%)

UBS analyst Laura…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$89.25 /

+0.94 (+1.06%)

NVS Novartis
$89.25 /

+0.94 (+1.06%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
NVS Novartis
$89.25 /

+0.94 (+1.06%)

NVS Novartis
$89.25 /

+0.94 (+1.06%)

NVS Novartis
$89.25 /

+0.94 (+1.06%)

Recommendations
Deutsche Boerse price target raised to EUR 165 from EUR 160 at UBS » 11:55
11/25/20
11/25
11:55
11/25/20
11:55
DBOEY

Deutsche Boerse

$0.00 /

+ (+0.00%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DBOEY Deutsche Boerse
$0.00 /

+ (+0.00%)

DBOEY Deutsche Boerse
$0.00 /

+ (+0.00%)

11/24/20 Oddo BHF
Deutsche Boerse upgraded to Buy from Neutral at Oddo BHF
11/19/20 Barclays
Deutsche Boerse price target raised to EUR 150 from EUR 142 at Barclays
10/30/20 Barclays
Deutsche Boerse price target lowered to EUR 142 from EUR 150 at Barclays
10/30/20 UBS
Deutsche Boerse price target lowered to EUR 160 from EUR 175 at UBS
Hot Stocks
WidePoint trading resumes  11:55
11/25/20
11/25
11:55
11/25/20
11:55
WYY

WidePoint

$8.40 /

+0.12 (+1.45%)

 
ShowHide Related Items >><<
WYY WidePoint
$8.40 /

+0.12 (+1.45%)

WYY WidePoint
$8.40 /

+0.12 (+1.45%)

03/03/20
LD Micro to hold a virtual conference
WYY WidePoint
$8.40 /

+0.12 (+1.45%)

Options
Plains GP Holdings put volume heavy and directionally bearish » 11:55
11/25/20
11/25
11:55
11/25/20
11:55
PAGP

Plains GP Holdings

$8.58 /

-0.14 (-1.61%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAGP Plains GP Holdings
$8.58 /

-0.14 (-1.61%)

PAGP Plains GP Holdings
$8.58 /

-0.14 (-1.61%)

09/25/20 Morgan Stanley
Morgan Stanley double upgrades Plains All American, Plains GP Holdings
09/25/20 Morgan Stanley
Plains GP Holdings upgraded to Overweight from Underweight at Morgan Stanley
07/21/20 BofA
Plains All American, Plains GP upgraded to Buy from Underperform at BofA
05/18/20 BofA
Plains All American, GP Holdings cut to Underperform at BofA
PAGP Plains GP Holdings
$8.58 /

-0.14 (-1.61%)

PAGP Plains GP Holdings
$8.58 /

-0.14 (-1.61%)

General news
State Street Investor Confidence Index data reported » 11:53
11/25/20
11/25
11:53
11/25/20
11:53

November State Street…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Boralex price target raised to C$42 from C$40 at RBC Capital » 11:50
11/25/20
11/25
11:50
11/25/20
11:50
BRLXF

Boralex

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BRLXF Boralex
$0.00 /

+ (+0.00%)

11/24/20 BMO Capital
Boralex price target raised to C$43 from C$41 at BMO Capital
11/23/20 Scotiabank
Boralex price target raised to C$46.25 from C$44.50 at Scotiabank
11/23/20 BMO Capital
Boralex price target raised to C$41 from C$39 at BMO Capital
11/12/20 BMO Capital
Boralex price target raised to C$39 from C$35 at BMO Capital
General news
FX Action: USD-JPY » 11:50
11/25/20
11/25
11:50
11/25/20
11:50

FX Action: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.